ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.52 Cr | ₹1.96 Cr | ₹1.63 Cr | ₹4.03 Cr | ₹4.14 Cr |
What is the latest Contingent Liabilities ratio of ALBERT DAVID ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4.52 Cr |
Mar2023 | ₹1.96 Cr |
Mar2022 | ₹1.63 Cr |
Mar2021 | ₹4.03 Cr |
Mar2020 | ₹4.14 Cr |
How is Contingent Liabilities of ALBERT DAVID Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.52 Cr | 130.38 | |
Mar2023 | ₹1.96 Cr | 20.22 | |
Mar2022 | ₹1.63 Cr | -59.46 | |
Mar2021 | ₹4.03 Cr | -2.78 | |
Mar2020 | ₹4.14 Cr | - |
Compare Contingent Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹488.6 Cr | 6.4% | 3.6% | -27.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | 6.4% |
3.6% |
-27.6% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses